开云app官网登录入口网页版-官方正版

#晚期食管癌#

18篇内容 | 1199人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2183453, encodeId=cc1d218345337, content=<a href='/topic/show?id=4323140286a' target=_blank style='color:#2F92EE;'>#Pembrolizumab#</a> <a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a> <a href='/topic/show?id=02bb11036040' target=_blank style='color:#2F92EE;'>#ASCO GI 2024#</a>, objectTitle=ASCO GI 2024：一线pembrolizumab+化疗治疗晚期食管癌：3期KEYNOTE-590研究的5年结果 , objectType=article, longId=810642, objectId=005881064236, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240122/1705890201768_8624274.png, objectUrl=/article/show_article.do?id=005881064236, replyNumber=0, likeNumber=63, createdTime=2024-01-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=005881064236, moduleTitle=ASCO GI 2024：一线pembrolizumab+化疗治疗晚期食管癌：3期KEYNOTE-590研究的5年结果 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=005881064236)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1551862, encodeId=3ead155186278, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=晚期食管癌一线治疗又添新突破：PD-1单抗「替雷利珠单抗」全球3期临床试验达到主要终点, objectType=article, longId=725482, objectId=de0ae25482c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de0ae25482c5, replyNumber=0, likeNumber=76, createdTime=2022-04-28, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de0ae25482c5, moduleTitle=晚期食管癌一线治疗又添新突破：PD-1单抗「替雷利珠单抗」全球3期临床试验达到主要终点, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=de0ae25482c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551861, encodeId=dd19155186104, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=Clin Cancer Res：晚期食管癌采用纳武单抗二线治疗的长期预后, objectType=article, longId=723436, objectId=90b1e23436f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90b1e23436f5, replyNumber=0, likeNumber=63, createdTime=2022-04-05, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90b1e23436f5, moduleTitle=Clin Cancer Res：晚期食管癌采用纳武单抗二线治疗的长期预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=90b1e23436f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551860, encodeId=80aa1551860c4, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=J Immunother Cancer：卡瑞利珠单抗+化疗作为局部晚期食管癌术前辅助治疗的疗效和安全性, objectType=article, longId=301810, objectId=b131301810c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b131301810c5, replyNumber=0, likeNumber=84, createdTime=2022-03-29, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b131301810c5, moduleTitle=J Immunother Cancer：卡瑞利珠单抗+化疗作为局部晚期食管癌术前辅助治疗的疗效和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b131301810c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551859, encodeId=cddd1551859f1, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=BMC Cancer：对于局部晚期食管癌，如cT1N+和cT2Nany，新辅助治疗或辅助治疗更优？, objectType=article, longId=292998, objectId=6f1329299826, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f1329299826, replyNumber=0, likeNumber=78, createdTime=2021-12-30, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f1329299826, moduleTitle=BMC Cancer：对于局部晚期食管癌，如cT1N+和cT2Nany，新辅助治疗或辅助治疗更优？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6f1329299826)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551858, encodeId=daa61551858a0, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=JAMA |我国学者：卡瑞丽珠单抗降低晚期食管癌患者3成生存率、4成无进展生存！, objectType=article, longId=217252, objectId=af4221e2529b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4221e2529b, replyNumber=0, likeNumber=61, createdTime=2021-09-19, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4221e2529b, moduleTitle=JAMA |我国学者：卡瑞丽珠单抗降低晚期食管癌患者3成生存率、4成无进展生存！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=af4221e2529b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551857, encodeId=dd35155185edd, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=Lancet子刊：放疗对晚期食管癌患者的吞咽困难无任何帮助！, objectType=article, longId=214517, objectId=d39121451e40, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d39121451e40, replyNumber=0, likeNumber=99, createdTime=2021-07-22, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d39121451e40, moduleTitle=Lancet子刊：放疗对晚期食管癌患者的吞咽困难无任何帮助！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d39121451e40)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551856, encodeId=7ce2155185640, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=JAMA Surg：局部晚期食管癌食管切除术前是新辅助放化疗还是新辅助化疗？, objectType=article, longId=208704, objectId=b07d208e046f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b07d208e046f, replyNumber=0, likeNumber=47, createdTime=2021-03-21, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b07d208e046f, moduleTitle=JAMA Surg：局部晚期食管癌食管切除术前是新辅助放化疗还是新辅助化疗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b07d208e046f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551855, encodeId=820c1551855c9, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=Lancet Gastroenterol Hepatol：晚期食管癌患者置入食管支架后是否有必要进行姑息性放疗？, objectType=article, longId=207513, objectId=a14420e513bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a14420e513bf, replyNumber=0, likeNumber=55, createdTime=2021-02-25, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a14420e513bf, moduleTitle=Lancet Gastroenterol Hepatol：晚期食管癌患者置入食管支架后是否有必要进行姑息性放疗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a14420e513bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551854, encodeId=b31c155185485, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=Ann Surg：微创食管切除术 vs 开胸食管切除术治疗的晚期食管癌患者的5年存活率, objectType=article, longId=206238, objectId=15492062389f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15492062389f, replyNumber=0, likeNumber=70, createdTime=2021-01-27, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15492062389f, moduleTitle=Ann Surg：微创食管切除术 vs 开胸食管切除术治疗的晚期食管癌患者的5年存活率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=15492062389f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551853, encodeId=1277155185321, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=纳武利尤单抗治疗晚期食管癌患者总生存期获益显著优于化疗，死亡风险降低23%，中位总生存期延长2.5个月, objectType=article, longId=180379, objectId=ffe41803e94e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffe41803e94e, replyNumber=0, likeNumber=0, createdTime=2019-10-03, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffe41803e94e, moduleTitle=纳武利尤单抗治疗晚期食管癌患者总生存期获益显著优于化疗，死亡风险降低23%，中位总生存期延长2.5个月, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ffe41803e94e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551852, encodeId=35b71551852ef, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=【ASCO-GI 2019】KEYNOTE-181研究亮相2019 ASCO-GI，PD-1单抗首次为晚期食管癌患者带来生存获益！, objectType=article, longId=158426, objectId=8f861584265c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f861584265c, replyNumber=0, likeNumber=77, createdTime=2019-01-20, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f861584265c, moduleTitle=【ASCO-GI 2019】KEYNOTE-181研究亮相2019 ASCO-GI，PD-1单抗首次为晚期食管癌患者带来生存获益！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8f861584265c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551851, encodeId=5ca515518516f, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=CSCO2018现场速递│晚期食管癌药物治疗新进展, objectType=article, longId=149673, objectId=e9221496e349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9221496e349, replyNumber=0, likeNumber=68, createdTime=2018-09-28, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9221496e349, moduleTitle=CSCO2018现场速递│晚期食管癌药物治疗新进展, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e9221496e349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551850, encodeId=c13215518504f, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=CLIN CANCER RES：SHR-1210治疗晚期食管癌的安全性、有效性及生物学标志, objectType=article, longId=133115, objectId=3d821331157c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d821331157c, replyNumber=0, likeNumber=57, createdTime=2018-03-24, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d821331157c, moduleTitle=CLIN CANCER RES：SHR-1210治疗晚期食管癌的安全性、有效性及生物学标志, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3d821331157c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551849, encodeId=f453155184948, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=JCO：Pembrolizumab治疗晚期食管癌的安全性和抗肿瘤活性, objectType=article, longId=119453, objectId=969e1194535f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=969e1194535f, replyNumber=0, likeNumber=51, createdTime=2017-11-11, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=969e1194535f, moduleTitle=JCO：Pembrolizumab治疗晚期食管癌的安全性和抗肿瘤活性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=969e1194535f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551848, encodeId=0246155184887, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=晚期食管癌何时放疗？中国学者给出了答案, objectType=article, longId=115184, objectId=955711518480, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=955711518480, replyNumber=0, likeNumber=0, createdTime=2017-10-05, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=955711518480, moduleTitle=晚期食管癌何时放疗？中国学者给出了答案, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=955711518480)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551847, encodeId=ab57155184e52, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=JNCI：晚期食管癌一线化疗方案哪家强？, objectType=article, longId=78035, objectId=e3b3e803531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3b3e803531, replyNumber=0, likeNumber=39, createdTime=2016-09-22, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3b3e803531, moduleTitle=JNCI：晚期食管癌一线化疗方案哪家强？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e3b3e803531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551846, encodeId=96ce1551846a5, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=CSMO 2014：樊青霞教授谈晚期食管癌的治疗策略, objectType=article, longId=37520, objectId=9d353e5209c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d353e5209c, replyNumber=0, likeNumber=59, createdTime=2014-07-09, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d353e5209c, moduleTitle=CSMO 2014：樊青霞教授谈晚期食管癌的治疗策略, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9d353e5209c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1551845, encodeId=dfba1551845c2, content=<a href='/topic/show?id=75d25989596' target=_blank style='color:#2F92EE;'>#晚期食管癌#</a>, objectTitle=Lancet Oncol：内照射支架可延长中晚期食管癌患者生存时间, objectType=article, longId=33611, objectId=2c103361194, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c103361194, replyNumber=0, likeNumber=66, createdTime=2014-04-23, rootId=0, userName=lq1772, userId=d93a14230733, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c103361194, moduleTitle=Lancet Oncol：内照射支架可延长中晚期食管癌患者生存时间, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2c103361194)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

晚期食管癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#Pembrolizumab# #晚期食管癌# #ASCO GI 2024#

ASCO GI 2024：一线pembrolizumab+化疗治疗晚期食管癌：3期KEYNOTE-590研究的5年结果

2024-01-23发表于上海

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

晚期食管癌一线治疗又添新突破：PD-1单抗「替雷利珠单抗」全球3期临床试验达到主要终点

2022-04-28

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

Clin Cancer Res：晚期食管癌采用纳武单抗二线治疗的长期预后

2022-04-05

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

J Immunother Cancer：卡瑞利珠单抗+化疗作为局部晚期食管癌术前辅助治疗的疗效和安全性

2022-03-29

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

BMC Cancer：对于局部晚期食管癌，如cT1N+和cT2Nany，新辅助治疗或辅助治疗更优？

2021-12-30

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

JAMA |我国学者：卡瑞丽珠单抗降低晚期食管癌患者3成生存率、4成无进展生存！

2021-09-19

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

Lancet子刊：放疗对晚期食管癌患者的吞咽困难无任何帮助！

2021-07-22

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

JAMA Surg：局部晚期食管癌食管切除术前是新辅助放化疗还是新辅助化疗？

2021-03-21

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

Lancet Gastroenterol Hepatol：晚期食管癌患者置入食管支架后是否有必要进行姑息性放疗？

2021-02-25

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

Ann Surg：微创食管切除术 vs 开胸食管切除术治疗的晚期食管癌患者的5年存活率

2021-01-27

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

纳武利尤单抗治疗晚期食管癌患者总生存期获益显著优于化疗，死亡风险降低23%，中位总生存期延长2.5个月

2019-10-03

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

【ASCO-GI 2019】KEYNOTE-181研究亮相2019 ASCO-GI，PD-1单抗首次为晚期食管癌患者带来生存获益！

2019-01-20

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

CSCO2018现场速递│晚期食管癌药物治疗新进展

2018-09-28

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

CLIN CANCER RES：SHR-1210治疗晚期食管癌的安全性、有效性及生物学标志

2018-03-24

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

JCO：Pembrolizumab治疗晚期食管癌的安全性和抗肿瘤活性

2017-11-11

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

晚期食管癌何时放疗？中国学者给出了答案

2017-10-05

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

JNCI：晚期食管癌一线化疗方案哪家强？

2016-09-22

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

CSMO 2014：樊青霞教授谈晚期食管癌的治疗策略

2014-07-09

lq1772 (审核中...)

前往app查看评论内容

#晚期食管癌#

Lancet Oncol：内照射支架可延长中晚期食管癌患者生存时间

2014-04-23

科室
- - 订阅+
  - 更多科室
工具
服务